Immunosuppression and Long-Term Survival after Heart Transplantation

被引：2
作者：
Dandel, M. [1 ]
机构：
[1] Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany
来源：
THORACIC AND CARDIOVASCULAR SURGEON | 2009年 / 57卷
关键词：
CARDIAC ALLOGRAFT VASCULOPATHY; MYCOPHENOLATE-MOFETIL; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; CONTROLLED-TRIAL; RECIPIENTS; CYCLOSPORINE; REGISTRY; AZATHIOPRINE; MULTICENTER;
D O I：
10.1055/s-2008-1039259
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S148 / S150
页数：3
相关论文
共 16 条
[1]   Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients -: The IMPROVED multi-centre study [J].
Angermann, CE ;
Störk, S ;
Costard-Jäckle, A ;
Dengler, TJ ;
Tenderich, G ;
Rahmel, A ;
Schwarz, ER ;
Nägele, H ;
Wagner, FM ;
Haaff, B ;
Pethig, K .
EUROPEAN HEART JOURNAL, 2004, 25 (18) :1626-1634
[2]   Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients [J].
Eisen, HJ ;
Kobashigawa, J ;
Keogh, A ;
Bourge, R ;
Renlund, D ;
Mentzer, R ;
Alderman, E ;
Valantine, H ;
Dureau, G ;
Mancini, D ;
Mamelok, R ;
Gordon, R ;
Wang, WD ;
Mehra, M ;
Constanzo, MR ;
Hummel, M ;
Johnson, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (05) :517-525
[3]   Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients [J].
Hamour, Iman M. ;
Lyster, Haifa S. ;
Burke, Margaret M. ;
Rose, Marlene L. ;
Banner, Nicholas R. .
TRANSPLANTATION, 2007, 83 (05) :570-576
[4]   Daclizumab to prevent rejection after cardiac transplantation [J].
Hershberger, RE ;
Starling, RC ;
Eisen, HJ ;
Bergh, CH ;
Kormos, RL ;
Love, RB ;
Van Bakel, A ;
Gordon, RD ;
Popat, R ;
Cockey, L ;
Mamelok, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2705-2713
[5]   Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: An analysis of the joint UNOS/ISHLT thoracic registry [J].
Hosenpud, JD ;
Bennett, LE .
TRANSPLANTATION, 2001, 72 (10) :1662-1665
[6]   Preventing cardiac allograft vasculopathy: Long-term beneficial effects of mycophenolate mofetil [J].
Kaczmarek, Ingo ;
Ertl, Bjoern ;
Schmauss, Daniel ;
Sadoni, Sebastian ;
Knez, Andreas ;
Daebritz, Sabine ;
Meiser, Bruno ;
Reichart, Bruno .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (05) :550-556
[7]   A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients [J].
Kobashigawa, J ;
Miller, L ;
Renlund, D ;
Mentzer, R ;
Alderman, E ;
Bourge, R ;
Costanzo, M ;
Eisen, H ;
Dureau, G ;
Ratkovec, R ;
Hummel, M ;
Ipe, D ;
Johnson, J ;
Keogh, A ;
Mamelok, R ;
Mancini, D ;
Smart, F ;
Valantine, H .
TRANSPLANTATION, 1998, 66 (04) :507-515
[8]   Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: Reanalysis of the multicenter trial [J].
Kobashigawa, JA ;
Tobis, JM ;
Mentzer, RM ;
Valantine, HA ;
Bourge, RC ;
Mehra, MR ;
Smart, FW ;
Miller, LW ;
Tanaka, K ;
Li, HY ;
Gjertson, DW ;
Gordon, RD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) :993-997
[9]   Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients [J].
Lehmkuhl, Hans B. ;
Mai, Daniel ;
Dandel, Michael ;
Knosalla, Christoph ;
Hiemann, Nicola E. ;
Grauhan, Onnen ;
Huebler, Michael ;
Pasic, Miralem ;
Weng, Yuguo ;
Meyer, Rudolph ;
Rothenburger, Markus ;
Hummel, Manfred ;
Hetzer, Roland .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (07) :700-704
[10]   Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients [J].
Morrisett, JD ;
Abdel-Fattah, G ;
Kahan, BD .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) :143S-150S
12